mk 0663 has been researched along with plx4032 in 1 studies
| Studies (mk 0663) | Trials (mk 0663) | Recent Studies (post-2010) (mk 0663) | Studies (plx4032) | Trials (plx4032) | Recent Studies (post-2010) (plx4032) |
|---|---|---|---|---|---|
| 549 | 173 | 265 | 1,657 | 103 | 1,587 |
| Protein | Taxonomy | mk 0663 (IC50) | plx4032 (IC50) |
|---|---|---|---|
| Chain A, AKAP9-BRAF fusion protein | Homo sapiens (human) | 0.031 | |
| RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | 0.182 | |
| Serine/threonine-protein kinase A-Raf | Homo sapiens (human) | 0.521 | |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | 0.0897 | |
| Serine/threonine-protein kinase B-raf | Mus musculus (house mouse) | 0.03 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.36 | |
| Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | 1.5 | |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | 1.5 | |
| Mitogen-activated protein kinase kinase kinase 20 | Homo sapiens (human) | 0.0272 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, A; Dömkes, S; Hillen, U; Livingstone, E; Schadendorf, D; Zimmer, L | 1 |
1 trial(s) available for mk 0663 and plx4032
| Article | Year |
|---|---|
Panniculitis with arthralgia in patients with melanoma treated with selective BRAF inhibitors and its management.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Arthralgia; Disease Progression; Dose-Response Relationship, Drug; Drug Eruptions; Etoricoxib; Female; Humans; Imidazoles; Indoles; Lymphatic Metastasis; Melanoma; Middle Aged; Neoplasm Staging; Oximes; Panniculitis; Point Mutation; Proto-Oncogene Proteins B-raf; Pyridines; Skin Neoplasms; Sulfonamides; Sulfones; Vemurafenib | 2012 |